Dr Syed Khalid Ali, MBBS, MS, PhD (HL)
Dr Khalid is a medical scientist with expertise in vaccinology and infectious diseases. He leads clinical research at Hilleman Laboratories, currently clinical development of oral Cholera vaccine Hillchol® and oral Shigella vaccine ShigOraVax. He was involved in clinical studies for Typhoid, Cholera, Polio, Pneumococcal Conjugate, Rotavirus and combination vaccines. Dr Khalid is also adjunct faculty at the Translational Health Sciences and Technology Institute, in Faridabad India. He leads groups working on development of novel vaccine delivery technologies. He is an investigator in projects funded by the European & Developing Countries Clinical Trials Partnership (EDCTP), Engineer and Physical Science Research Council UK, Department of Biotechnology India, and has previously worked on projects funded by the US National Institute of Health and Bill and Melinda Gates Foundation.